Arecor Therapeutics plc (AIM:AREC)
82.75
+2.75 (3.44%)
Oct 15, 2026, 2:51 PM GMT
Arecor Therapeutics Revenue
Arecor Therapeutics had revenue of 194.00K GBP in the half year ending June 30, 2026, a decrease of -90.28%. This brings the company's revenue in the last twelve months to 890.00K, down -78.16% year-over-year. In the year 2025, Arecor Therapeutics had annual revenue of 1.71M with 4.32% growth. That makes Arecor Therapeutics the 43,319th largest company in the world by revenue and 863rd in the United Kingdom.
Revenue (ttm)
890.00K
Revenue Growth
-78.16%
P/S Ratio
40.72
Revenue / Employee
26.97K
Employees
33
Market Cap
37.49M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.71M | 71.00K | 4.32% |
| Dec 31, 2024 | 1.64M | -2.93M | -64.07% |
| Dec 31, 2023 | 4.57M | 2.17M | 90.30% |
| Dec 31, 2022 | 2.40M | 1.25M | 107.51% |
| Dec 31, 2021 | 1.16M | -540.00K | -31.80% |
| Dec 31, 2020 | 1.70M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Bioventix | 12.54M |
| IXICO | 7.28M |
| SkinBioTherapeutics | 5.23M |
| Ondine Biomedical | 1.53M |
| Oxford BioDynamics | 1.20M |
| Faron Pharmaceuticals Oy | 1.14M |
| 4basebio | 781.00K |
| ImmuPharma | -69.96K |
Arecor Therapeutics News
- 3 days ago - Half Year 2026 Arecor Therapeutics PLC Earnings Presentation Transcript - GuruFocus
- 15 days ago - Arecor Therapeutics Quarterly report: H1 2026 - Filings
- 3 months ago - Arecor Therapeutics Slides: Investor presentation - Filings
- 5 months ago - Arecor Therapeutics Earnings Call Transcript: H2 2025 - Transcripts
- 5 months ago - Arecor Therapeutics Annual report: H2 2025 - Filings
- 5 months ago - Arecor Therapeutics Slides: H2 2025 - Filings
- 5 months ago - Arecor Therapeutics Annual report: H2 2025 - Filings
- 7 months ago - Arecor Therapeutics Transcript: Oppenheimer 36th Annual Healthcare MedTech & Services Conference - Transcripts